Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
Kidney Int Rep
.
2020 Jun 17;5(8):1375.
doi: 10.1016/j.ekir.2020.05.031.
eCollection 2020 Aug.
Authors
Marion Delafosse
1
,
Camille Saint-Jaques
2
,
Camille Petit-Hoang
3
,
Hélène François
3
,
Julie Peltier
4
,
Laurence Nicolet
4
,
Charles Verney
5
,
Martin Viguier
5
,
Emmanuel Letavernier
1
2
,
Karine Dahan
6
7
Affiliations
1
UMRS 1155, Sorbonne Université INSERM, Paris, France.
2
Physiology Unit, Assistance Publique des Hôpitaux de Paris, Hôpital Tenon, Paris, France.
3
Intensive Care Nephrology and Transplantation Department, Assistance Publique des Hôpitaux de Paris, Hôpital Tenon, Paris, France.
4
Nephrology Unit, Clinique Edouard Rist, Paris, France.
5
Department of Infectious Diseases Assistance Publique des Hôpitaux de Paris, Hôpital Tenon, Paris, France.
6
Nephrology Unit, Assistance Publique des Hôpitaux de Paris, Hôpital Tenon, Paris, France.
7
ANDRA, B Braun Nephrology Center, Paris, France.
PMID:
32775845
PMCID:
PMC7298510
DOI:
10.1016/j.ekir.2020.05.031
No abstract available